AN AUSTRALIAN Public Assessment Report (AusPAR) has been posted for Mayne Pharma's Ephedrine Hydrochloride, around approval of a major variation, namely a new strength of 25mg/mL.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jul 17